References
- 1ParkDW, BoldtHC, MessicotteSJ, et al. subacute sclerosing panencephalitis manifesting as viral retinitis: clinical and histopathologic findings. Am J Ophthalmol 1997;123:533–542. doi: 10.1016/S0002-93949394(14)70179-59124250
- 2SwovelandPT, JohnsonKP Subacute sclerosing panencephalitis and other paramyxovirus infections. In: MckendallRR, editor. Handbook of clinical neurology. Vol 12 (56). Virus diseases. Amsterdam: North Holland Publishing Company; 1989, pp. 417–437.
- 3SahaV, JohnTJ, MukundanP, et al. High incidence of subacute sclerosing panencephalitis in South India. Epidemiol Infect 1990;104:151–156. doi: 10.1017/S09502688000546372307182
- 4Dyken PR. Subacute sclerosing panencephalitis. Neurol Clin 1985;3:179–195.2581121
- 5ElmaliAD, SimsekogluR, SahinE, IlkiCD, et al. Senile-onset subacute sclerosing panencephalitis, presenting with peculiar findings. Clin EEG Neurosci 2018;50(4):283–286. doi: 10.1177/155005941879375830099908
- 6TanakaJ, NakamuraH, FukadaT Adult-onset subacute sclerosing panencephalitis: immunocytochemical and electron microscopic demonstration of the viral antigen. Clin Neuropathol 1987;6:30–37.3552353
- 7GagnonA, BouchardRW Fulminating adult-onset subacute sclerosing panencephalitis in a 49-year-old man. Arch Neurol 2003;60:1160–1161. doi: 10.1001/archneur.60.8.116012925376
- 8ColpakAI, ErdenerSE, OzgenB, AnlarB, KansuT Neuro-ophthalmology of subacute sclerosing panencephalitis: two cases and a review of the literature. Curr Opin Ophthalmol 2012;23:466–471. doi: 10.1097/ICU.0b013e328358b19623047165
- 9OztürkA, GürsesC, BaykanB, GökyigitA, EraksoyM Subacute sclerosing panencephalitis: clinical and magnetic resonance imaging evaluation of 36 patients. J Child Neurol 2002;17:25–29. doi: 10.1177/08830738020170010611913565
- 10BurtonK, FarellK, LiD Lesions of the putamen and dystonia, CT and MR imaging. Neurology 1984;34:962–965. doi: 10.1212/WNL.34.7.9626539874
- 11BhatiaK, MarsdenCD The behavior and motor consequences of the focal lesions of basal ganglia in man. Brain 1994;117:859–876. doi: 10.1093/brain/117.4.8597922471
- 12SharmaP, SinghD, SinghMK, GargRK, KohliN Brainstem involvement in subacute sclerosing panencephalitis. Neurol India 2011;59:273–275. doi: 10.4103/0028-3886.7914621483132
- 13lkanA, KorkmazL, SigirciA, et al. Subacute sclerosing panencephalitis: relationship between clinical stage and diffusion-weighted imaging findings. J Magn Reson Imaging 2006;23:267–272. doi: 10.1002/jmri.2051816456844
- 14DimovaP, BojinovaV Subacute sclerosing panencephalitis with atypical onset: clinical, computed tomographic, and magnetic resonance imaging correlations. J Child Neurol 2000;15:258–260. doi: 10.1177/08830738000150041110805193
- 15MisraK, RoyA Parkinsonian presentation of SSPE: report of two cases. Neurol Asia 2008;13:117–120.
- 16SawaishiY, YanoT, WatanbeY, et al. Migratory basal ganglia lesions in subacute scleorising panencephalitis (SSPE). Clinical implications ofaxonal spread. J Neurol Sci 1999;168:137–140. doi: 10.1016/S0022-510X(99)00177-X10526197
- 17GutierrezJ, IssacsonR, KoppelB Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol 2010;52:901–907. doi: 10.1111/j.1469-8749.2010.03717.x20561004
- 18HuttenlocherPR, MattsonRH Isoprinosine in subacute sclerosing panencephalitis. Neurology 1979;29:763–771. doi: 10.1212/WNL.29.6.76388024
- 19TaylorWJ, DuRantRH, DykenPR Treatment of subacute sclerosing panencephalitis: an overview. Drug Intell Clin Pharm 1984;18:375–381. doi: 10.1177/1060028084018005036202474
- 20AnlarB, AydinOF, GuvenA, SonmezFM, KoseG, HergunerO Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis. Clin Ther 2004;26:1890–1894. doi: 10.1016/j.clinthera.2004.11.00215639700
- 21GargRK Subacute sclerosing panencephalitis. BMJ J 2002;78:63–70. doi: 10.1136/pmj.78.916.63
- 22MorrowJI, DoweyKE, SwallowMW Subacute sclerosing panencephalitis in Northern Ireland: twenty years’ experience. Ulster Med J 1986:55:124–130.3811010
- 23McQuaidS, CosbySL, KoffiK, HondeM, KirkJ, LucasSB Distribution of measles virus in the central nervous system of HIV-seropositive children. Acta Neuropathol 1998;96:637–642. doi: 10.1007/s0040100509459845294
- 24World Health Organization (WHO) Global Advisory Committee on Vaccine Safety. Wkly Epidemiol Rec 2006;81:13–20. Available from: https://www.who.int/vaccine_safety/committee/reports/wer8102.pdf?ua=1 [cited 13 January 2006].
- 25World Health Organization (WHO) Global Health Observatory data repository. Measles, 1st dose (MCV1) Immunization coverage estimates by country Available from: http://apps.who.int/gho/data/node.main.A826 [cited 19 July 2018].